PTC-2105
Asset
Targets declining mitochondrial membrane potential to restore mitochondrial efficiency and induce senescent-cell apoptosis.
- Stage
- Preclinical
- Modality
- Peptide
- Target
- Not known
- 3
- Indications
- 0
- Trials
- 1
- Developer
Indications
3Obesity
Preclinical, eossenolytix.com, 10 Oct 2026
Sarcopenia
Preclinical, eossenolytix.com, 10 Oct 2026
Sarcopenic obesity
Preclinical, eossenolytix.com, 10 Oct 2026
In the full profile
- Owner and partners1
- Competitors12
Every asset’s record: target, stage, trials and the evidence behind it.